ArcBest Corporation (ARCB)       70.8  +0.43 (+0.61%)

70.8  +0.43 (+0.61%)

US03937C1053 - Common Stock - After market: 70.8 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 121.89. This target is 72.16% above the current price.
ARCB was analyzed by 16 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ARCB.
In the previous month the buy percentage consensus was at a similar level.
ARCB was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 70.8087.87129.03121.89150.15 - 24.11% 82.25% 72.16% 112.08%

Up and Down Grades

Date Firm Action Rating
2022-06-28 Credit Suisse Initiate Outperform
2022-05-18 Morgan Stanley Maintains Overweight
2022-04-08 B of A Securities Downgrade Buy -> Neutral
2022-03-09 B of A Securities Maintains Buy
2022-02-02 Goldman Sachs Maintains Neutral
2021-11-09 Morgan Stanley Maintains Overweight
2021-10-19 B of A Securities Maintains Buy
2021-10-05 Truist Securities Maintains Buy
2021-10-04 Morgan Stanley Maintains Overweight
2021-09-30 Cowen & Co. Maintains Outperform
2021-07-14 Citigroup Maintains Buy
2021-06-29 Truist Securities Maintains Buy
2021-06-08 Vertical Research Upgrade Hold -> Buy
2021-06-07 Goldman Sachs Downgrade Buy -> Neutral
2021-06-04 Wolfe Research Downgrade Outperform -> Peer Perform
2021-05-27 Morgan Stanley Maintains Overweight
2021-04-15 Truist Securities Maintains Buy
2021-03-26 Vertical Research Initiate Hold
2021-03-25 Morgan Stanley Maintains Overweight
2021-02-17 Morgan Stanley Maintains Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA